GlassScriptPhysician profile
Eric Y Chang
NPI 1376756353
$10,776.97
in general payments reported to CMS, 2019-2025
11 companies · $342 in 2025
The $342 reported for 2025 was more than what 75% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,596 · 2022: $4,214 · 2023: $172 · 2024: $1,452 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861 · Travel and Lodging: $605 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $861.48 |
| Travel and Lodging | $605.27 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Joint Restoration Foundation, INC. | $7,200.00 | 2021-2022 | |
| Tersera Therapeutics LLC | $1,596.00 | 2021 | |
| Reflexion Medical, INC. | $745.92 | 2024 | Reflexion Medical Radiotherapy System |
| Endo Pharmaceuticals INC. | $500.00 | 2024 | |
| Stryker Corporation | $233.36 | 2024-2025 | Pangea, Variax |
| Saluda Medical Americas, INC. | $172.49 | 2023 | Evoke Scs |
| Icotec Medical INC. | $141.63 | 2024 | Vader Pedicle System, Icotec Blackarmor Spine System |
| Siemens Medical Solutions USA, INC. | $104.36 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.66 | 2025 | Relistor |
| Merz Pharmaceuticals, LLC | $28.33 | 2025 | Xeomin |
| Trice Medical, INC. | $14.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.